Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma

Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single agent in patients with melanoma resulted in involution of tumors associated with inhibition of both the mitogen-activated protein kinase (MAP...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Abushahba, Walid, Olabisi, Oyenike O., Jeong, Byeong-Seon, Boregowda, Rajeev K., Wen, Yu, Liu, Fang, Goydos, James S., Lasfar, Ahmed, Cohen-Solal, Karine A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3470581/
https://ncbi.nlm.nih.gov/pubmed/23077590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047312
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak